Commitments and Contingencies - Narrative (Details)				1 Months Ended		6 Months Ended
	May 01, 2024 USD ($) D $ / shares	Jan. 26, 2024 USD ($) D $ / shares shares	Dec. 11, 2023 D $ / shares	May 31, 2024 $ / shares shares	Apr. 30, 2022	Jun. 30, 2024 USD ($)
Convertible promissory note payable, related party						$ 1,940,000
Original Convertible promissory note
Aggregate amount of notes issued		$ 2,250,000
Interest rate percentage on the note		1.00%
Maturity of issuance		1 year
Debt instrument conversion price | $ / shares		$ 0.39109	$ 78.22
Volume weighted average price		110.00%	110.00%
Debt instrument trading days | D		7	7
Convertible note		$ 1,985,750
Debt instrument conversion of shares issued upon conversion (in shares) | shares		29,053
Amended convertible promissory note
Aggregate amount of notes issued	$ 2,250,000
Interest rate percentage on the note	1.00%
Debt instrument conversion price | $ / shares	$ 78.22	$ 78.22		$ 22.00
Volume weighted average price	110.00%	110.00%
Debt instrument trading days | D	7	7
Debt instrument conversion of shares issued upon conversion (in shares) | shares				106,908
Amended convertible promissory note | Scenario where company consummates a public financing within 60 days of May 1, 2024
Aggregate amount of notes issued	$ 2,250,000
Debt instrument conversion price | $ / shares				$ 22.00
Volume weighted average price	110.00%			110.00%
Debt instrument trading days | D	60
Debt instrument conversion of shares issued upon conversion (in shares) | shares				103,908
Elusys Therapeutics
Earn out payment period					12 years
Percentage of earn out payments					10.00%
Frequency of periodic earn out payment					1 year
Period of occurrence of earn payment					9 years
Future commitments						$ 51,400,000